Full Text
PNS179 HOW DOES EXTERNAL REFERENCE PRICING FOR MEDICARE PART B DRUGS COMPARE TO OTHER COST METRICS AVAILABLE IN THE UNITED STATES?

Abstract

Authors

J. Levy T.J. Mattingly B.N. Ippolito

Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×